Features of intracardiac hemodynamics in patients with acute myocardial infarction with st segment elevation who underwent COVID-19

Objective: to evaluate the features of central and intracardiac hemodynamics in patients with ST-segment elevation myocardial infarction (STEMI), who underwent COVID-19 during inpatient stay and 6 months after the development of STEMI. Materials and methods. 140 patients with STEMI were included in the study. The patients were randomized into 2 groups: I - main group - patients with STEMI who suffered COVID-19 (52 people) in the period from 1.5-6 months before the development of acute coronary syndrome (ACS), II - comparison group (88 people) which included patients with STEMI who did not have COVID-19 in the anamnesis. All patients underwent PCI with stenting of the infarct-related artery in the first 24 hours from the onset of ACS. The parameters of central and intracardiac hemodynamics in all patients were determined for 2-3 days (1^st control point), 9-11 days (2^nd control point), after 6 months (3^rd control point) from the moment of hospitalization for STEMI. Results. In the patients of the main group of the study, more pronounced changes in the systolic-diastolic LV function were recorded on the 2-3 day of STEMI: LV EF by 8.5%, Sm by 7.2% and E' by 24.5% (p<0.05) were lower than in the control group, respectively, E/E' by 11.5% and WMSI by 21.8% (p<0.05) were higher than in the comparison group. On the 9^th-11^th day of the disease in patients with STEMI who underwent COVID-19, a slowdown in the recovery of the studied parameters was revealed: the LV EF value was lower than in the control group by 11%, Sm by 12% and E' by 20% (p<0.05), respectively, and the value of E/E' by 27% and WMSI by 25% (p<0.05) were higher than in the comparison group. 6 months after STEMI, there were no significant differences in Sm, E', E/E' values in the main and control groups, however, a lower LVEF and WMSI value was noted in comparison with the control group (p<0.05). Conclusion. Unidirectional positive dynamics of systolic-diastolic function parameters in hospital and post-hospital follow-up periods was observed in patients with STEMI, both those who had COVID-19 and without COVID-19 in the anamnesis. However, in patients who underwent COVID-19, there were more pronounced violations of LV systolic-diastolic function on 2-3 days and less pronounced, delayed positive dynamics of these parameters during the hospital and post-hospital treatment periods.

1. Drapkina O.M., Samorodskaya I.V. Trends in regional mortality rates from heart diseases in Russia in 2019-2020. Kardiologiya. 2022;62(10):16-25 (in Russ.). DOI: 10.17116/profmed20222512164. EDN: HTAYLL.

2. Kravtsiva A.V., Gulyaeva A.A., Golovanova E.D., Ayrapetov K.V. Damage to the cardiovascular system in COVID-19. Vestnik Smolensk State Medical University. 2021;20(4):59-65 (in Russ.). DOI: 10.37903/vsgma.2021.4.8. EDN UQCINE.

3. Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ. 2021;372:n693. DOI: 10.1136/bmj.n693.

4. Shlyakhto E.V., Konradi A.O., Arutyunov G.P., Arutyunov A.G., Bautin A.E., Boytsov S.A., Villeval’de S.V., Grigor’yeva N.Yu., et al. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic.Russian Journal of Cardiology. 2020;25(3):129-148 (in Russ.). DOI: 10.15829/1560-4071-2020-3-3801. EDN: NTALPB.

5. Tinaeva R.Sh., Skvortsov V.V. The effect of COVID-19 on the human vascular system. Medsestra. 2021;(7):72-79 (in Russ.). DOI: 10.33920/med-05-2107-06. EDN: YNFIFL.

6. Tsygan N.V., Ryabtsev A.V., Odinak M.M., Litvinenko I.V. The incidence and pathophysiology of neurological symptoms in COVID-19. Izvestiya Rossiyskoy Voyenno-meditsinskoy akademii. 2021;40(4):33-42 (in Russ.). DOI: 10.17816/rmmar83617. EDN: ZBDGSB.

7. Martynov M.Yu., Bogolepova A.N., Yasamanova A.N. Endothelial dysfunction in COVID-19 and cognitive impairment. Zhurnal Nevrologii I Psikhiatrii imeni S.S. Korsakova. 2021;121(6):93-99 (in Russ.). DOI: 10.17116/jnevro202112106193. EDN: IRHFWS.

8. Nagibovich O.A., Zakharov M.V., Shelukhin V.A., Aksenov V.V., Shipilova D.A. Kidney damage due to novel coronavirus infection. Vestnik terapevta. 2021;51(4):24-37 (in Russ.). EDN: IHGZNL.

9. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. DOI: 10.1016/S0140-6736(20)30183-5.

10. Barbarash O.L., Karetnikova V.N., Kashtalap V.V., Zvereva T.N., Kochergina A.M. New coronavirus disease (COVID-19) and cardiovascular disease. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy. 2020;9(2):17-28 (in Russ.). DOI: 10.17802/2306-1278-2020-9-2-17-28. EDN: LJIYBE.

11. Katsoularis I., Fonseca-Rodríguez O., Farrington P., Lindmark K., Fors Connolly A.M. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398(10300):599-607. DOI: 10.1016/S0140-6736(21)00896-5.

12. Nagashima S., Mendes M.C., Camargo Martins A.P., Borges N.H., Godoy T.M., Miggiolaro A.F.R.D.S., da Silva Dezidério F., Machado-Souza C., et al. Endothelial Dysfunction and Thrombosis in Patients With COVID-19-Brief Report. Arterioscler Thromb Vasc Biol. 2020;40(10):2404-2407. DOI: 10.1161/ATVBAHA.120.314860.

13. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-943. DOI: 10.1001/jamainternmed.2020.0994.

14. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. DOI: 10.1016/S0140-6736(20)30183-5.

15. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003. (in Chin.)

16. Roitman E.V. The recovery of endothelial function in novel coronavirus infection COVID-19 (review). Meditsinskiy sovet. 2021;(14): 78-86. (in Russ.). DOI: 10.21518/2079-701X-2021-14-78-86. EDN: VACMHR.

17. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. DOI: 10.1016/j.cell.2020.02.052.

18. Robinson F.A., Mihealsick R.P., Wagener B.M., Hanna P., Poston M.D., Efimov I.R., Shivkumar K., Hoover D.B. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection. Am J Physiol Heart Circ Physiol. 2020;319(5):H1059-H1068. DOI: 10.1152/ajpheart.00681.2020.

19. Libby P., Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41(32):3038-3044. DOI: 10.1093/eurheartj/ehaa623.

20. Tersalvi G., Vicenzi M., Calabretta D., Biasco L., Pedrazzini G., Winterton D. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms. J Card Fail. 2020;26(6):470-475. DOI: 10.1016/j.cardfail.2020.04.009

21. Zeng J.H., Liu Y.X., Yuan J., Wang F.X., Wu W.B., Li J.X., Wang L.F., Gao H., et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48(5):773-777. DOI: 10.1007/s15010-020-01424-5.

22. Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. DOI: 10.1016/j.eclinm.2020.100683.

23. Khorolets E.V. Cardiovascular complications in rheumatoid arthritis. Glavnyy vrach Yuga Rossii.2020;2(72):39-43 (in Russ.). EDN XYJRML.

24. Clinical recommendations. Acute myocardial infarction with ST elevation electrocardiogram (in Russ.). URL: https://cr.minzdrav.gov.ru/recomend/157_4

25. Arutyunov G.P., Paleyev F.N., Moiseyeva O.M., Dragunov D.O., Sokolova A.V., Arutyunov A.G., Zhirov I.V., Blagova O.V., et al. 2020 Clinical practice guidelines for Myocarditis in adults.Russian Society of Cardiology. 2021;26(11):136-182 (in Russ.). DOI: 10.15829/1560-4071-2021-4790. EDN: SWZXVO.

26. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. DOI: 10.1016/j.euje.2005.12.014.

27. Galderisi M., Cosyns B., Edvardsen T., Cardim N., Delgado V., Di Salvo G., Donal E., Sade L.E., et al. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017;18(12):1301-1310. DOI: 10.1093/ehjci/jex244.

28. Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F. 3rd, Dokainish H., Edvardsen T., Flachskampf F.A., Gillebert T.C., et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321-1360. DOI: 10.1093/ehjci/jew082.

29. Rybakova M.K., Mitkov V.V., Baldin D.G. Echocardiography by M.K. Rybakova. Moscow: Publishing house Vidar-M, 2016. 600 с. (in Russ.)

30. Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F. 3rd, Dokainish H., Edvardsen T., Flachskampf F.A., et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4): 277-314. DOI: 10.1016/j.echo.2016.01.011

31. Alekhin M.N., Kalinin A.O. Left ventricular diastolic function: value of left atrial global longitudinal strain. Ul’trazvukovaya i funktsional’naya diagnostika. 2020;(3):91-104 (in Russ.). DOI: 10.24835/1607-0771-2020-3-91-104. EDN: YDCDKW.

32.

33. Akhmentaeva D.A., Kapsultanova D.A., Lisovenko O.I. et al. Influence of COVID 19 coronavirus infection on the severity of coronary heart disease course and the risk of acute myocardial infarction. Bulletin of KazNMU. 2022;(1):121-127 (in Russ.). EDN: CGEOWI.

34. Jankowska-Sanetra J., Sanetra K., Konopko M., Kutowicz M., Synak M., Kachel M., Kazmierczak P.E., Milewski K., et al. Incidence and course of acute coronary syndromes cases following first wave of COVID-19 pandemy. European Heart Journal. 2021;42(S1):ehab724.1359. DOI: 10.1093/eurheartj/ehab724.1359.

35. Lee C., Patel N., Penepinto L., Byers M., Ambrosino M., Adusunalli S., Denduluri S., Cohen J., et al. The role of premorbid transthoracic echocardiogram in identifying adverse clinical outcomes in patients admitted with COVID-19. European Heart Journal, 2021;42(1):ehab724.0103. DOI: 10.1093/eurheartj/ehab724.0103

36. Aronov D.M., Barbarash O.L., Bubnova M.G.Russian clinical guidelines. Rehabilitation and secondary prevention in patients with acute myocardial infarction with ST segment elevation. Moscow: Ministry of Health of the Russian Federation, 2014. 98 p. (in Russ.). URL: https://scardio.ru/content/Guidelines/Project_reabilit_190514.pdf.